A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
L01 ANTINEOPLASTIC AGENTS
|
L01A ALKYLATING AGENTS
|
L01B ANTIMETABOLITES
|
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
|
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
|
L01E PROTEIN KINASE INHIBITORS
|
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
|
L01FA CD20 (Clusters of Differentiation 20) inhibitors
|
L01FB CD22 (Clusters of Differentiation 22) inhibitors
|
L01FC CD38 (Clusters of Differentiation 38) inhibitors
|
L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
|
L01FD01 Trastuzumab
|
L01FD02 Pertuzumab
|
L01FD03 Trastuzumab emtansine
|
D09980 Trastuzumab emtansine (USAN/INN) <JP/US>
|
L01FD04 Trastuzumab deruxtecan
|
L01FD05 Trastuzumab duocarmazine
|
L01FD06 Margetuximab
|
L01FD07 Zanidatamab
|
L01FE EGFR (Epidermal Growth Factor Receptor) inhibitors
|
L01FF PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
|
L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors
|
L01FX Other monoclonal antibodies and antibody drug conjugates
|
L01FY Combinations of monoclonal antibodies and antibody drug conjugates
|
L01X OTHER ANTINEOPLASTIC AGENTS
|
L02 ENDOCRINE THERAPY
|
L03 IMMUNOSTIMULANTS
|
L04 IMMUNOSUPPRESSANTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|